Stephen J. Aselage
2011
In 2011, Stephen J. Aselage earned a total compensation of $5.1M as Executive Vice President & Chief Business Officer at BioMarin Pharmaceutical, a 198% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $164,939 |
|---|---|
| Option Awards | $1,036,800 |
| Salary | $382,288 |
| Stock Awards | $3,525,900 |
| Other | $8,856 |
| Total | $5,118,783 |
Aselage received $3.5M in stock awards, accounting for 69% of the total pay in 2011.
Aselage also received $164.9K in non-equity incentive plan, $1M in option awards, $382.3K in salary and $8.9K in other compensation.
Rankings
In 2011, Stephen J. Aselage's compensation ranked 1,051st out of 10,747 executives tracked by ExecPay. In other words, Aselage earned more than 90.2% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 1,051 out of 10,747 | 90th |
Division Manufacturing | 392 out of 3,960 | 90th |
Major group Chemicals And Allied Products | 90 out of 1,038 | 91st |
Industry group Drugs | 52 out of 786 | 93rd |
Industry Pharmaceutical Preparations | 47 out of 571 | 92nd |
Source: SEC filing on March 23, 2012.
Aselage's colleagues
We found four more compensation records of executives who worked with Stephen J. Aselage at BioMarin Pharmaceutical in 2011.